LicianPro

NEKTAR THERAPEUTICS ·

NKTR 8-K 2026-09-25

NEKTAR THERAPEUTICS (NKTR) 8-K dated 2026-09-25 — accession 0001213900-26-103215.

NEKTAR THERAPEUTICS (NKTR) is a biotechnology company listed on US.

NEKTAR THERAPEUTICS filed a 8-K on 2026-09-25. Accession 0001213900-26-103215.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported NKTR revenue for 2025-12-31 was $55.2M. Net income was -$164.1M. Revenue was down 43.9% from 2024-12-31 to 2025-12-31. NKTR currently screens at market cap $307.2M.

Not investment advice. The NKTR SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr